| Date | Title | | | 02/02/10 | Life Technologies Responds to Challenge of Detecting Vesivirus 2117 Contamination in Mammalian Cell Culture Manufacturing| New Molecular Test Provides Rapid Sample Preparation and qPCR Method for Specific and Sensitive Detection of This RNA Virus
CARLSBAD, Calif., Feb 02, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE) today announced a new molecular test for the detection of Vesivirus 2117, a potential contaminant of mammalian cell culture based biopharmaceutical manufacturing. The Applied Biosystems ViralSEQTM Vesivirus Detection Kit is a highly sensitive and accurate test that enables the q... |
|  | | 02/01/10 | Life Technologies Completes Divestiture of Mass Spectrometry Business| CARLSBAD, Calif., Feb 01, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation (NYSE: DHR) for $450 million in cash, subject to a conventional working capital adjustment.
Danaher has also acquired Life Technologies' joint venture partner in the business, MDS Analytical Technologies, a division of MDS Inc. (NYSE: MDZ). Mass spect... |
| | | 01/28/10 | Life Technologies and Ignite Institute Partner to Create Largest Next Generation Genomic Sequencing Facility in North America| CARLSBAD, Calif. & FAIRFAX, Va., Jan 28, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE) and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia. Ignite will acquire 100 of the Applied Biosystems SOLiD(TM) 4 Systems, the most advanced next generation DNA sequencing platform on the market, establishing the largest concentration of genetic analytical po... |
| | | 01/28/10 | Life Technologies Announces Fourth Quarter and Fiscal Year 2009 Results| Fourth quarter GAAP earnings per share of $0.26, and non-GAAP earnings per share of $0.80Free cash flow of $187 million in the fourth quarter, and full year free cash flow of $534 million
CARLSBAD, Calif., Jan 28, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increas... |
| | | 01/27/10 | Life Technologies Brings Genomic Sequencing Closer to the Clinic| Company announces SOLiD(TM) 4 System, delivering industry's most cost effective, highest quality genome for $6,000, reduced to $3,000 by end of 2010 with SOLiD(TM) 4hq upgrade
Company introduces BioScope(TM) software solution, announces major investment to address bioinformatics challenges
Life Technologies Foundation announces $5 million in grants to accelerate physician education in molecular medicine
CARLSBAD, Calif., Jan 27, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NAS... |
| | | 01/21/10 | Applied Biosystems Forensic DNA Kit Approved for Use by the National DNA Index System| Addition of DNA Profiles to FBI Database Expected to Increase Links of Potential Suspects to Crimes
CARLSBAD, Calif., Jan 21, 2010 (BUSINESS WIRE) -- Applied Biosystems, part of LifeTechnologies Corporation (NASDAQ:LIFE) today announced that its AmpFℓSTR® MiniFiler™ PCR Amplification Kit has been approved for inclusion in the National DNA Index System (NDIS), a United States Federal Bureau of Investigation database that facilitates the electronic comparison and exchange of DNA profiles betwee... |
| | | 01/12/10 | Life Technologies Signs Definitive Agreement to Acquire AcroMetrix|
Acquisition Adds to Company's Strengths in Molecular Diagnostic Offerings
CARLSBAD, Calif., Jan 12, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire AcroMetrix, for an undisclosed amount.
AcroMetrix is a provider of molecular and serological diagnostic quality control products to clinical laboratories, blood screening centers and in-vitro diagnostic (IV... |
| | | 01/11/10 | Life Technologies Sets 4th Quarter and Full Year 2009 Earnings
Release Date for Thursday, January 28, 2010| CARLSBAD, Calif., Jan 11, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) announced today it will
report its fourth quarter and full year 2009 financial results on
Thursday, January 28, 2010, before market open. The company will also
hold a conference call on the same day at 8:30 a.m. EST to discuss
operating results, as well as future expectations.
The webcast can be accessed through the investor relations page of the
Life Technologi... |
| |
|
